Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: E9AW26
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 186 | 190 | PF00656 | 0.601 |
CLV_C14_Caspase3-7 | 25 | 29 | PF00656 | 0.344 |
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.334 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.609 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.466 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.585 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.355 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.363 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.611 |
CLV_PCSK_PC1ET2_1 | 130 | 132 | PF00082 | 0.385 |
CLV_PCSK_PC7_1 | 105 | 111 | PF00082 | 0.338 |
CLV_PCSK_PC7_1 | 11 | 17 | PF00082 | 0.615 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.404 |
DEG_APCC_DBOX_1 | 66 | 74 | PF00400 | 0.377 |
DOC_MAPK_gen_1 | 15 | 22 | PF00069 | 0.431 |
DOC_MAPK_MEF2A_6 | 15 | 22 | PF00069 | 0.445 |
DOC_MAPK_NFAT4_5 | 15 | 23 | PF00069 | 0.446 |
DOC_PP1_RVXF_1 | 78 | 85 | PF00149 | 0.294 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.350 |
DOC_USP7_UBL2_3 | 45 | 49 | PF12436 | 0.329 |
LIG_14-3-3_CanoR_1 | 11 | 15 | PF00244 | 0.414 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.412 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.505 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.405 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.340 |
LIG_FHA_2 | 184 | 190 | PF00498 | 0.577 |
LIG_Integrin_RGD_1 | 106 | 108 | PF01839 | 0.288 |
LIG_LIR_Gen_1 | 17 | 26 | PF02991 | 0.316 |
LIG_LIR_Gen_1 | 85 | 94 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 17 | 22 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.385 |
LIG_Pex14_2 | 93 | 97 | PF04695 | 0.420 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.501 |
LIG_TRAF2_1 | 116 | 119 | PF00917 | 0.616 |
LIG_WRC_WIRS_1 | 94 | 99 | PF05994 | 0.383 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.417 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.483 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.420 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.627 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.329 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.557 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.631 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.399 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.475 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.418 |
MOD_N-GLC_1 | 30 | 35 | PF02516 | 0.706 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.366 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.437 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.478 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.433 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.481 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.360 |
MOD_NEK2_2 | 14 | 19 | PF00069 | 0.304 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.419 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.353 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.377 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.365 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.578 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.331 |
MOD_SUMO_rev_2 | 135 | 141 | PF00179 | 0.519 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.449 |
TRG_ER_diArg_1 | 104 | 106 | PF00400 | 0.522 |
TRG_ER_diArg_1 | 14 | 16 | PF00400 | 0.413 |
TRG_Pf-PMV_PEXEL_1 | 153 | 157 | PF00026 | 0.428 |
TRG_PTS2 | 1 | 40 | PF00400 | 0.420 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2Y2 | Leptomonas seymouri | 49% | 100% |
A0A0S4JFQ3 | Bodo saltans | 34% | 100% |
A0A3S7WXI2 | Leishmania donovani | 81% | 100% |
A4HCN8 | Leishmania braziliensis | 68% | 100% |
A4I063 | Leishmania infantum | 82% | 100% |
Q4QBF1 | Leishmania major | 82% | 100% |